Cargando…

Keeping communities at the centre of efforts to eliminate lymphatic filariasis: learning from the past to reach a future free of lymphatic filariasis

Since the launch of the Global Programme to Eliminate Lymphatic Filariasis (GPELF) in 2000, more than 910 million people have received preventive chemotherapy for lymphatic filariasis (LF) and many thousands have received care for chronic manifestations of the disease. To achieve this, millions of c...

Descripción completa

Detalles Bibliográficos
Autores principales: Krentel, Alison, Gyapong, Margaret, McFarland, Deborah A, Ogundahunsi, Olumide, Titaley, Christiana R, Addiss, David G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753171/
https://www.ncbi.nlm.nih.gov/pubmed/33349882
http://dx.doi.org/10.1093/inthealth/ihaa086
_version_ 1783626015142051840
author Krentel, Alison
Gyapong, Margaret
McFarland, Deborah A
Ogundahunsi, Olumide
Titaley, Christiana R
Addiss, David G
author_facet Krentel, Alison
Gyapong, Margaret
McFarland, Deborah A
Ogundahunsi, Olumide
Titaley, Christiana R
Addiss, David G
author_sort Krentel, Alison
collection PubMed
description Since the launch of the Global Programme to Eliminate Lymphatic Filariasis (GPELF) in 2000, more than 910 million people have received preventive chemotherapy for lymphatic filariasis (LF) and many thousands have received care for chronic manifestations of the disease. To achieve this, millions of community drug distributors (CDDs), community members and health personnel have worked together each year to ensure that at-risk communities receive preventive chemotherapy through mass drug administration (MDA). The successes of 20 y of partnership with communities is celebrated, including the application of community-directed treatment, the use of CDDs and integration with other platforms to improve community access to healthcare. Important challenges facing the GPELF moving forward towards 2030 relate to global demographic, financing and programmatic changes. New innovations in research and practice present opportunities to encourage further community partnership to achieve the elimination of LF as a public health problem. We stress the critical need for community ownership in the current Covid-19 pandemic, to counter concerns in relaunching MDA programmes for LF.
format Online
Article
Text
id pubmed-7753171
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77531712020-12-29 Keeping communities at the centre of efforts to eliminate lymphatic filariasis: learning from the past to reach a future free of lymphatic filariasis Krentel, Alison Gyapong, Margaret McFarland, Deborah A Ogundahunsi, Olumide Titaley, Christiana R Addiss, David G Int Health Review Since the launch of the Global Programme to Eliminate Lymphatic Filariasis (GPELF) in 2000, more than 910 million people have received preventive chemotherapy for lymphatic filariasis (LF) and many thousands have received care for chronic manifestations of the disease. To achieve this, millions of community drug distributors (CDDs), community members and health personnel have worked together each year to ensure that at-risk communities receive preventive chemotherapy through mass drug administration (MDA). The successes of 20 y of partnership with communities is celebrated, including the application of community-directed treatment, the use of CDDs and integration with other platforms to improve community access to healthcare. Important challenges facing the GPELF moving forward towards 2030 relate to global demographic, financing and programmatic changes. New innovations in research and practice present opportunities to encourage further community partnership to achieve the elimination of LF as a public health problem. We stress the critical need for community ownership in the current Covid-19 pandemic, to counter concerns in relaunching MDA programmes for LF. Oxford University Press 2020-12-22 /pmc/articles/PMC7753171/ /pubmed/33349882 http://dx.doi.org/10.1093/inthealth/ihaa086 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Review
Krentel, Alison
Gyapong, Margaret
McFarland, Deborah A
Ogundahunsi, Olumide
Titaley, Christiana R
Addiss, David G
Keeping communities at the centre of efforts to eliminate lymphatic filariasis: learning from the past to reach a future free of lymphatic filariasis
title Keeping communities at the centre of efforts to eliminate lymphatic filariasis: learning from the past to reach a future free of lymphatic filariasis
title_full Keeping communities at the centre of efforts to eliminate lymphatic filariasis: learning from the past to reach a future free of lymphatic filariasis
title_fullStr Keeping communities at the centre of efforts to eliminate lymphatic filariasis: learning from the past to reach a future free of lymphatic filariasis
title_full_unstemmed Keeping communities at the centre of efforts to eliminate lymphatic filariasis: learning from the past to reach a future free of lymphatic filariasis
title_short Keeping communities at the centre of efforts to eliminate lymphatic filariasis: learning from the past to reach a future free of lymphatic filariasis
title_sort keeping communities at the centre of efforts to eliminate lymphatic filariasis: learning from the past to reach a future free of lymphatic filariasis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753171/
https://www.ncbi.nlm.nih.gov/pubmed/33349882
http://dx.doi.org/10.1093/inthealth/ihaa086
work_keys_str_mv AT krentelalison keepingcommunitiesatthecentreofeffortstoeliminatelymphaticfilariasislearningfromthepasttoreachafuturefreeoflymphaticfilariasis
AT gyapongmargaret keepingcommunitiesatthecentreofeffortstoeliminatelymphaticfilariasislearningfromthepasttoreachafuturefreeoflymphaticfilariasis
AT mcfarlanddeboraha keepingcommunitiesatthecentreofeffortstoeliminatelymphaticfilariasislearningfromthepasttoreachafuturefreeoflymphaticfilariasis
AT ogundahunsiolumide keepingcommunitiesatthecentreofeffortstoeliminatelymphaticfilariasislearningfromthepasttoreachafuturefreeoflymphaticfilariasis
AT titaleychristianar keepingcommunitiesatthecentreofeffortstoeliminatelymphaticfilariasislearningfromthepasttoreachafuturefreeoflymphaticfilariasis
AT addissdavidg keepingcommunitiesatthecentreofeffortstoeliminatelymphaticfilariasislearningfromthepasttoreachafuturefreeoflymphaticfilariasis